Is ICUI or RGC more profitable?

ICUI runs the higher net margin — ICUI at 1.39% versus RGC at 0.00%.

How have ICUI and RGC total returns compared?

Over the past 5 years, ICUI delivered -7.18% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.

ICU Medical, Inc. (ICUI) vs Regencell Bioscience Holdings Limited (RGC)

A side-by-side comparison of ICU Medical, Inc. and Regencell Bioscience Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ICUI

ICU Medical, Inc.

$3.97B

$159.01HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

RGC

Regencell Bioscience Holdings Limited

$3.59B

$7.25HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT

Total return — ICUI vs RGC

growth of $100 · dividends reinvested · last 5y

ICUI -20.9% (-4.6%/yr)RGC +2520.2% (+92.2%/yr)RGC compounded faster over this window

Log scale — wide-divergence pair

ICUI RGC

ICUI vs RGC: by the numbers

•ICUI is the larger company ($3.97B vs $3.59B market cap).
•ICUI is profitable (1.39% net margin) while RGC runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	ICUI	RGC
P/E ratio	134.75	N/A
P/S ratio	1.84	N/A
P/B ratio	1.85	2945.91
EV / EBITDA	13.61	N/A
FCF yield	3.85%	N/A

Profitability

Metric	ICUI	RGC
Gross margin	37.56%	0.00%
Operating margin	5.04%	0.00%
Net margin	1.39%	0.00%
ROE	1.40%	-73.75%
ROIC	3.11%	-69.75%

Growth (annualized)

Metric	ICUI	RGC
Revenue CAGR (5Y)	11.05%	N/A
EPS CAGR (5Y)	-62.79%	N/A
FCF CAGR (5Y)	-2.65%	N/A
Total return CAGR (5Y)	-7.18%	67.94%

Frequently asked

Is ICUI or RGC more profitable?: ICUI runs the higher net margin — ICUI at 1.39% versus RGC at 0.00%.
How have ICUI and RGC total returns compared?: Over the past 5 years, ICUI delivered -7.18% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ICUI analysis Full RGC analysis Interactive comparison tool

Dig into the metrics

ICU Medical P/E ratio ICU Medical ROE Regencell Bioscience ROE ICU Medical operating margin Regencell Bioscience operating margin ICU Medical revenue growth Regencell Bioscience revenue growth ICU Medical free cash flow Regencell Bioscience free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.